Dual-modality, dual-functional nanoprobes for cellular and molecular imaging

Theranostics

Volumn 2, Issue 12, 2012, Pages 1199-1207

  Menon, Jyothi U ^a   Gulaka, Praveen K ^b   McKay, Madalyn A ^a   Geethanath, Sairam ^b   Liu, Li ^a   Kodibagkar, Vikram D ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Arizona State University   (United States)

Author keywords

Dual modality; Fluorescence; hexamethyldisiloxane; MR oximetry; Nanoemulsions; Nile Red

Indexed keywords

DYE; HEXAMETHYLDISILOXANE; NILE RED DYE; PHOSPHATIDYLCHOLINE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG DELIVERY SYSTEM; FLUORESCENCE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIGHT SCATTERING; MOLECULAR IMAGING; NANOEMULSION; NANOPROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; OXYGEN TENSION; PARTICLE SIZE;

DUAL-MODALITY.; FLUORESCENCE; HEXAMETHYLDISILOXANE; MR OXIMETRY; NANOEMULSIONS; NILE RED;

ANIMALS; CELL SURVIVAL; ENDOCYTOSIS; FIBROBLASTS; HUMANS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; NANOPARTICLES; NIH 3T3 CELLS; OXAZINES; PARTICLE SIZE; SILOXANES;

EID: 84881540882     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4812     Document Type: Article

References (47)

1. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 2007;21:1037-49.
2. Wachsberger P, Burd R, Dicker AP. Tumor Response to Ionizing Radiation Combined with Antiangiogenesis or Vascular Targeting Agents. Clinical Cancer Research. 2003;9:1957-71.
3. Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?. Oncologist. 2004;9 Suppl 5:31-40.
4. Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biology. 2003;22:81-91.
5. Volkmer E, Drosse I, Otto S, Stangelmayer A, Stengele M, Kallukalam BC, et al. Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue engineering Part A. 2008;14:1331-40.
6. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue engineering. 2007;13:1325-31.
7. Femandes TG, Diogo MM, Femandes-Platzgummer A, Lobato da Silva C, Cabral JMS. Effect of hypoxia on proliferation and neural commitment of embryonic stem cells at different stages of pluripotency. Bioengineering (ENBENG), 2011 ENBENG 2011 1st Portuguese Meeting. 2011:1-4.
8. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR in biomedicine. 2004;17:484-99.
9. Bhirde A, Xie J, Swierczewska M, Chen X. Nanoparticles for cell labeling. Nanoscale. 2011;3:142-53.
10. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR American journal of roentgenology. 2009;193:314-25.
11. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Current pharmaceutical biotechnology. 2004;5:567-84.
12. Temme S, Bonner F, Schrader J, Flogel U. 19F magnetic resonance imaging of endogenous macrophages in inflammation. Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology. 2012;4:329-43.
13. Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T. In vivo tracking of human neural stem cells with 19F magnetic resonance imaging. PloS one. 2011;6:e29040.
14. Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magnetic Resonance in Medicine. 2011;65:1144-53.
15. Zhang H. Perfluoro-15-crown-5 ether-labeled dendritic cells. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD). 2004.
16. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2007;21:1647-54.
17. Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, et al. Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging. 2010;54:259-80.
18. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods in enzymology. 2004;386:378-418.
19. Kodibagkar VD, Wang X, Pacheco-Torres J, Gulaka P, Mason RP. Proton imaging of siloxanes to map tissue oxygenation levels (PISTOL): a tool for quantitative tissue oximetry. NMR in biomedicine. 2008;21:899-907.
20. Kodibagkar VD, Cui W, Merritt ME, Mason RP. Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magnetic Resonance in Medicine. 2006;55:743-8.
21. Gulaka PK, Rastogi U, McKay MA, Wang X, Mason RP, Kodibagkar VD. Hexamethyldisiloxane-based nanoprobes for 1H MRI oximetry. NMR in biomedicine. 2011;24:1226-34.
22. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid In. 2005;10:102-10.
23. Wang XY, Ju S, Li C, Peng XG, Chen AF, Mao H, et al. Non-invasive Imaging of Endothelial Progenitor Cells in Tumor Neovascularization Using a Novel Dual-modality Paramagnetic/Near-Infrared Fluorescence Probe. PloS one. 2012;7:e50575.
24. Jarzyna PA, Deddens LH, Kann BH, Ramachandran S, Calcagno C, Chen W, et al. Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. Neoplasia. 2012;14:964-73.
25. Key J, Cooper C, Kim AY, Dhawan D, Knapp DW, Kim K, et al. In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles. Journal of controlled release. 2012;163:249-55.
26. Bumb A, Regino CA, Egen JG, Bernardo M, Dobson PJ, Germain RN, et al. Trafficking of a dual-modality magnetic resonance and fluorescence imaging superparamagnetic iron oxide-based nanoprobe to lymph nodes. Molecular imaging and biology. 2011;13:1163-72.
27. Kessinger CW, Khemtong C, Togao O, Takahashi M, Sumer BD, Gao J. In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes. Exp Biol Med. 2010;235:957-65.
28. Zhou J, Sun Y, Du X, Xiong L, Hu H, Li F. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials. 2010;31:3287-95.
29. Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, et al. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjugate chemistry. 2007;18:1474-82.
30. Uzgiris EE, Sood A, Bove K, Grimmond B, Lee D, Lomnes S. A multimodal contrast agent for preoperative MR Imaging and intraoperative tumor margin delineation. Technology in cancer research & treatment. 2006;5:301-9.
31. Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano letters. 2006;6:1459-63.
32. Lalande C, Miraux S, Derkaoui SM, Mornet S, Bareille R, Fricain JC, et al. Magnetic resonance imaging tracking of human adipose derived stromal cells within three-dimensional scaffolds for bone tissue engineering. European cells & materials. 2011;21:341-54.
33. Kamaly N, Kalber T, Kenny G, Bell J, Jorgensen M, Miller A. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI. Organic & biomolecular chemistry. 2010;8:201-11.
34. Montet-Abou K, Daire JL, Hyacinthe JN, Jorge-Costa M, Grosdemange K, Mach F, et al. In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardium. European heart journal. 2010;31:1410-20.
35. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, et al. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. NeuroImage. 2004;21:311-7.
36. Wei L, Li G, Yan YD, Pradhan R, Kim JO, Quan Q. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization. Archives of pharmacal research. 2012;35(6):1037-43.
37. Hoeller S, Sperger A, Valenta C. Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. International Journal of Pharmaceutics. 2009;370:181-6.
38. Jain R, Patravale VB. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J Biomed Nanotechnol. 2009;5:62-8.
39. Bhowmik BB, Sa B, Mukherjee A. Preparation and in vitro characterization of slow release testosterone nanocapsules in alginates. Acta Pharm. 2006;56:417-29.
40. Porras M, Solans C, González C, Martínez A, Guinart A, Gutiérrez JM. Studies of formation of W/O nano-emulsions. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2004;249:115-8.
41. Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM. Nanoemulsions: formation, structure, and physical properties. J Phys-Condens Mat. 2006;18:R635-R66.
42. Coon JS, Knudson W, Clodfelter K, Lu B, Weinstein RS. Solutol HS 15, Nontoxic Polyoxyethylene Esters of 12-Hydroxystearic Acid, Reverses Multidrug Resistance. Cancer research. 1991;51:897-902.
43. Paolino D, Ventura CA, Nisticò S, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. International Journal of Pharmaceutics. 2002;244:21-31.
44. Shen J, Khan N, Lewis LD, Armand R, Grinberg O, Demidenko E, et al. Oxygen consumption rates and oxygen concentration in molt-4 cells and their mtDNA depleted (rho0) mutants. Biophysical journal. 2003;84:1291-8.
45. Streeter I, Cheema U. Oxygen consumption rate of cells in 3D culture: the use of experiment and simulation to measure kinetic parameters and optimise culture conditions. The Analyst. 2011;136:4013-9.
46. Diepart C, Verrax J, Calderon PB, Feron O, Jordan BF, Gallez B. Comparison of methods for measuring oxygen consumption in tumor cells in vitro. Analytical biochemistry. 2010;396:250-6.
47. He X, Gao J, Gambhir SS, Cheng Z. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends in molecular medicine. 2010;16:574-83.